February 2014

Pathology & Laboratory Medicine News Items

Announcements:

  • Nancy Miller, M.D. has been appointed as a member of the Editorial Board for Annals of Clinical and Medical Microbiology. The Annals of Clinical and Medical Microbiology was recently launched and solicited editorial board members. From the journal’s website Annals of Clinical and Medical Microbiology is an international, open access, peer reviewed journal that brings about latest research in all clinical and medical aspects of clinical and medical microbiology. This journal focus upon the most recent research associated with the prognosis, laboratory diagnosis of human and animal infections and understanding the role of the pathogens in both infectious diseases as well as in the exposition of epidemiology of infections.” Dr. Miller’s expertise will be utilized to assure that only papers of the highest quality are accepted for publication. More information about the journal may be found at their website: http://www.jscimedcentral.com/MedicalMicrobiology/
  • Jessica (Allen) Ritter, PhD Candidate in the Genco Lab will be presenting a poster entitled, “Neisseria gonorrhoeae modulates immune cell survival through pyroptosis” at the 2014 Annual Meeting of the Sexually Transmitted Infections Cooperative Research Centers February 19th-21st, 2014 in Cambridge, MA
  • Dr. Huihong Xu was invited to give a lecture on “Frozen Section Diagnosis” at China Shanghai Fudan University Cancer Hospital, Department of Pathology, on January 28th, 2014
  • Nancy S. Miller, M.D. presented “Point of Care Meets Microbiology: Preparing for the next frontier at point-of-care”, at the Department of Laboratory Medicine Seminar Series, Yale University School of Medicine on February 21st
  • Once again on Monday, February 10th the Graduate School of Medical Sciences held another successful PIBS Graduate Program Interview Day. The full day for 53 candidates consisted of a breakfast; an overview of the programs BUSM has to offer (Pathology included); 3-4 interviews with faulty; lunch with Program Directors and Department Chairs; tours and an end-of-day Poster/Interview session. Representatives for Pathology at the Poster/Interview session included: Faculty – Drs. Susan Winandy, New Graduate Program Director, Krzysztof Blusztajn, Daniel Remick, Barbara Slack, and Jackie Sharon as well as current PhD candidates; Parul Agnihotri, Zach Hunter, Caitlin Leibowitz, Caitlin Miller, Jess Ritter and Nicole Stauffer. Thank you all for sharing your time and research!
  • Blood Bank News:
    • CAP was in for a very successful inspection of AP and CP on January 14
    • The Federation for Accreditation of Cellular Therapies (FACT) came for a planned assessment of the complete Stem Cell Transplant Program, including the Blood Bank Stem Cell Processing Lab on January 27. Very successful!
    • While we were still catching our breath, the FDA arrived unannounced on January 30 till February 3 for an extremely thorough inspection of all blood bank functions.  The FDA views Blood Banks as “manufacturers” and all processes that affect the safety, purity and potency of the blood product were scrutinized.  The FDA found no deviations or deficiencies in any of our processes.  All FDA inspections are unannounced and occur roughly every 2 years.
  • Charline Mack has been officially/formally named Manager for Anatomic Pathology. Charline is a wonderful leader for our Anatomic Pathology Department, as well as playing a broader management role within the Department of Pathology & Laboratory Medicine. Please join me in congratulating Charline!

Publications: PUBLISHED:

  • Treon, Steven P, Yang Cao, Lian Xu, Guang Yang, Xia Liu, and Zachary R Hunter. “Somatic Mutations in MYD88 and CXCR4 Are Determinants of Clinical Presentation and Overall Survival in Waldenstrom’s Macroglobulinemia.” Blood (February 19, 2014). doi:10.1182/blood-2014-01-550905
  • Xu, L, Z R Hunter, G Yang, Y Cao, X Liu, R Manning, C Tripsas, et al. “Detection of MYD88 L265P in Peripheral Blood of Patients with Waldenström’s Macroglobulinemia and IgM Monoclonal Gammopathy of Undetermined Significance.” Leukemia (February 10, 2014). doi:10.1038/leu.2014.65